- £1.10bn
- £2.26bn
- £4.76bn
- 37
- 61
- 89
- 70
2019 March 31st | R2020 March 31st | R2021 March 27th | 2022 March 26th | 2023 March 25th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 52 W | 52 W | 52 W |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7,127 | 4,643 | 4,319 | 4,591 | 4,755 |
Cost of Revenue | |||||
Gross Profit | 1,582 | 1,008 | 1,179 | 1,217 | 1,283 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 7,117 | 4,858 | 4,148 | 4,468 | 4,601 |
Operating Profit | 9.8 | -215 | 171 | 123 | 154 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -97.9 | -338 | 29.1 | -17.7 | 97.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -108 | -335 | 22.8 | -5.8 | 86.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -66.9 | -327 | 78.4 | 636 | 87.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -66.9 | -327 | 78.4 | 636 | 87.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.046 | -0.156 | -0.132 | -0.049 | 0.198 |
Dividends per Share | |||||
Special Dividends per Share |